Cargando…
Bacterial resistance to CRISPR-Cas antimicrobials
In the age of antibiotic resistance and precise microbiome engineering, CRISPR-Cas antimicrobials promise to have a substantial impact on the way we treat diseases in the future. However, the efficacy of these antimicrobials and their mechanisms of resistance remain to be elucidated. We systematical...
Autores principales: | Uribe, Ruben V., Rathmer, Christin, Jahn, Leonie Johanna, Ellabaan, Mostafa Mostafa Hashim, Li, Simone S., Sommer, Morten Otto Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390487/ https://www.ncbi.nlm.nih.gov/pubmed/34446818 http://dx.doi.org/10.1038/s41598-021-96735-4 |
Ejemplares similares
-
Compatibility of Evolutionary Responses to Constituent Antibiotics Drive Resistance Evolution to Drug Pairs
por: Jahn, Leonie Johanna, et al.
Publicado: (2021) -
Dominant resistance and negative epistasis can limit the co-selection of de novo resistance mutations and antibiotic resistance genes
por: Porse, Andreas, et al.
Publicado: (2020) -
Adaptive Laboratory Evolution of Antibiotic Resistance Using Different Selection Regimes Lead to Similar Phenotypes and Genotypes
por: Jahn, Leonie J., et al.
Publicado: (2017) -
Forecasting the dissemination of antibiotic resistance genes across bacterial genomes
por: Ellabaan, Mostafa M. H., et al.
Publicado: (2021) -
Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections
por: Imamovic, Lejla, et al.
Publicado: (2018)